🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase Ⅱ, single-center, randomized, double-blind, placebo-control...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2020-11-17
Trial ID
NCT04640402
Treatments Being Tested
A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein V...
Status
Unknown
Location
Multiple Locations
Start Date
2024-12-30
Trial ID
NCT05911048
A phase Ⅱ, observer-blind, randomized, controlled, investigator-initiated c...
Status
Completed
Location
Iloilo Doctors Hospital
Start Date
2022-07-11
Trial ID
NCT05463354
Treatments Being Tested
This is a phase Ⅱb, single-center, randomized, double-blind, placebo-contro...
Status
Withdrawn
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2021-02-01
Trial ID
NCT04718467
Treatments Being Tested
This is a randomized, double-blind , non-inferiority design study, to evalu...
Status
Completed
Location
Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2022-07-20
Trial ID
NCT05465785
Treatments Being Tested
The Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) developed ...
Status
Unknown
Location
Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2023-12-19
Trial ID
NCT06175494
This is a phase I, single-center, randomized, placebo-controlled, double-bl...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2020-08-28
Trial ID
NCT04530656
Treatments Being Tested
This is a phase Ⅰ/Ⅱ, single-center, randomized, double-blind, placebo-contr...
Status
Withdrawn
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2024-07
Trial ID
NCT05013983
Treatments Being Tested
A observer-blind, randomized, controlled, investigator-initiated clinical t...
Status
Completed
Location
West China Hospital of Sichuan University
Start Date
2022-08-02
Trial ID
NCT06381843
Treatments Being Tested
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta)...
Status
Unknown
Location
Multiple Locations
Start Date
2024-12-30
Trial ID
NCT05911061